Clinical Trials Sponsored by Thomas Gardner

Total 1556 results

Thomas Gardner

Suspended

SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction (SLINDO)

Epiphora | Dacryocystorhinostomy

United States
Thomas Gardner
Juvenile Diabetes Research Foundation

Completed

Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy (POC1)

Diabetic Retinopathy

United States
Thomas Gardner
Juvenile Diabetes Research Foundation; Penn State University

Completed

Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy (POC2)

Diabetic Retinopathy

United States
Sir Charles Gairdner Hospital

Completed

Catheter Over Needle vs Catheter Through Needle

Nerve Block | Catheterization

Australia
Sir Charles Gairdner Hospital

Completed

Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients

End Stage Kidney Disease

Australia
Sir Charles Gairdner Hospital

Unknown

Thyroxine Titration Study

Hypothyroidism

Australia
Sir Charles Gairdner Hospital

Unknown

Topical Magnesium and Muscle Cramps in Dialysis Patients.

Chronic Kidney Diseases | End Stage Renal Disease | Dialysis Related Complications
Sir Charles Gairdner Hospital

Completed

Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

Anemia | Kidney Failure, Chronic

Australia
Sir Charles Gairdner Hospital

Completed

Short Term Effects of FX Dialysers on QOL and Inflammation

Kidney Failure, Chronic

Australia
Warner Chilcott

Terminated

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

Neurogenic Detrusor Overactivity

United States, Colombia
Warner Chilcott

Completed

Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women (VENUS)

Postmenopausal Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Postmenopausal Osteoporosis

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction II

Erectile Dysfunction

United States
Warner Chilcott

Completed

Asacol Acute Diverticulitis(DIVA)Study

Diverticulitis

United States
Warner Chilcott

Completed

Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder (HSDD)

United States, Australia, Canada
Warner Chilcott

Completed

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Australia
Warner Chilcott

Completed

Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Urogential Chlamydia Trachomatis Infection

United States
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure (CORDELIA)

Heart Failure

United States
Warner Chilcott

Completed

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) (ASCEND I)

Ulcerative Colitis

United States
Warner Chilcott

Completed

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

Vulvovaginal Atrophy

United States
Warner Chilcott

Completed

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Ulcerative Colitis

United States, Canada, Puerto Rico
Warner Chilcott

Completed

Fecal Biomarker Study for Patients With Ulcerative Colitis

Ulcerative Colitis

United States
Warner Chilcott

Completed

A Comparison of Once a Day Dose Compared to 2 Doses/Day

Ulcerative Colitis

United States, Canada, Puerto Rico
Warner Chilcott

Completed

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Estonia, Hungary, Poland, Canada, France, Argentina, Belgium
Warner Chilcott

Completed

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

Osteogenesis Imperfecta

Chile, United States, Spain, Australia, Belgium, United Kingdom, Czech Republic, Finland, Germany, Hungary, Italy, Poland, South Africa
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Completed

A Double Blind Study for the Treatment of Acute Ulcerative Colitis

Ulcerative Colitis

United States, Canada, Hungary, Belarus, Croatia, Czech Republic, Estonia, Latvia, Lithuania, Poland, Puerto Rico, Romania, Russian Federation, Serbia, Ukraine
Warner Chilcott

Terminated

A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.

Ulcerative Colitis

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States
Warner Chilcott

Completed

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Osteopenia

United Kingdom, Argentina, Australia, Canada, France, Germany, Switzerland
Warner Chilcott

Completed

Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women

Hypoactive Sexual Desire Disorder

United States
Warner Chilcott

Completed

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Postmenopausal Women With Osteoporosis

Spain, Australia, Belgium, Denmark, Finland, Italy, Poland, Sweden
David Gardner
Dalhousie University; University of New Brunswick

Completed

Protocol - Your Answers When Needing Sleep in New Brunswick (YAWNS NB)

Insomnia Chronic

Canada
Partner Therapeutics, Inc.

Completed

Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation

Drug Kinetics | Drug Effects on Physiology

Canada
Hospital Erasto Gaertner

Completed

Uterine Transposition: Feasibility Study

Postoperative Complications | Intraoperative Complications | Ovarian Failure | Tissue Damage | Uterus Disorder

Brazil
Warner Chilcott

Completed

A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

Menopause | Vulvovaginal Atrophy | Dyspareunia

United States
Warner Chilcott

Completed

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Warner Chilcott

Completed

Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

Erectile Dysfunction

United States
Warner Chilcott

Terminated

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

Erectile Dysfunction

United States
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Completed

Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.

Hormone Replacement Therapy

United States
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Prevention of Pregnancy

United States
Warner Chilcott

Completed

Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Warner Chilcott

Completed

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States, Canada, Australia
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Canada, Australia, United States
Warner Chilcott

Completed

Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

Hypoactive Sexual Desire Disorder

Australia, Botswana, Canada, Germany, United Kingdom

Clinical Trials Sponsored by Thomas Gardner

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations